Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104676) titled 'A Clinical Study of Tablet Oligen (Shigru) as as Antioxidant Effect (Rasayan) Along With Shatapushpa Tail Nasya in Oligomenorrhoea (Artavkshay) Associated in pcos' on Feb. 24.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Other Method of allocation concealment:Case Record Numbers Blinding and masking:Open Label
Primary Sponsor: Dr Rajvee Ramakant Patil
Condition:
Health Condition 1: N914- Secondary oligomenorrhea
Recruitment Status: Not Recruiting
Phase: Phase 2/ Phase 3
Date of First Enrollment: 05-03-2026
Target Sample S...